Is Wegovy safe for heart patients — and what should you know before starting?

You have heart disease and you've been told Wegovy might help, here's what that's based on

This situation comes up often. Someone has been living with heart failure, a previous heart attack, or angina; their weight is a contributing problem; and a GP or cardiologist mentions semaglutide almost in passing. It can feel like a lot to take in.

The evidence behind that recommendation is solid. The SELECT trial (a large, placebo-controlled study in adults with established cardiovascular disease and a BMI of 27 or above, published in the New England Journal of Medicine) found that semaglutide 2.4 mg reduced the combined rate of heart attack, stroke and cardiovascular death by around 20% over a mean follow-up of just over three years. Participants had not been selected for their blood sugar levels; most did not have diabetes. This was a weight-and-cardiovascular signal, not a diabetes-management finding.

On the strength of that data, Wegovy holds a UK licence not just for weight management but also for reducing major cardiovascular event risk in adults with obesity or overweight and pre-existing heart disease. The NHS medicines page for semaglutide describes both indications. Knowing this matters: if a cardiologist has mentioned Wegovy, they are drawing on peer-reviewed evidence, not a hunch.

That said, the SELECT population was adults with established disease who were clinically stable. The trial was not designed around people with very recent acute coronary events, decompensated heart failure, or complex arrhythmias. If your situation is more acute, timing and clinical stability become part of the prescriber's assessment, which is exactly why these medicines require a thorough clinical review rather than a click-and-buy route.

Side effects that matter more when your heart is already working hard

The most common side effects of Wegovy are gastrointestinal: nausea, vomiting, diarrhoea, constipation, and sometimes reflux or burping. For most people these are most noticeable in the first weeks of treatment or after a dose increase, and they ease as the body adjusts. Our full Wegovy side-effect guide covers this in detail, including typical timing.

For someone with cardiovascular disease, a few of these deserve specific attention. Repeated vomiting or diarrhoea can lead to dehydration, which matters if you are taking diuretics, ACE inhibitors, or other medicines whose dosing depends on stable fluid balance and kidney function. Letting your GP or cardiologist know you are starting Wegovy means they can watch for this, rather than discovering a problem after the fact.

Semaglutide also produces a modest, consistent rise in resting heart rate of roughly one to two beats per minute on average, a small effect, but one prescribers consider when heart rate control is clinically important (for example, in atrial fibrillation managed with rate-limiting medicines). This is not a reason to rule out treatment, but it belongs in the clinical picture.

Pancreatitis is a less common but serious concern with GLP-1 medicines. The MHRA issued a Drug Safety Update on this in January 2026, confirming that acute pancreatitis is a known, infrequent risk: the symptom to act on is severe stomach pain that spreads to the back and does not settle, with or without vomiting. Anyone experiencing this should seek emergency care immediately. You can read more about Wegovy's general safety profile and the signals the MHRA monitors, and report any suspected side effect at the MHRA's Yellow Card scheme.

When to get medical help, and what can usually wait until your next appointment

Knowing the difference is practical, not alarmist. Call 999 or go to A&E immediately for: chest pain or tightness; sudden severe breathlessness; signs of stroke (facial drooping, arm weakness, slurred speech); severe persistent stomach pain radiating to the back (possible pancreatitis); or symptoms of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing).

Contact your GP or prescriber within a day or two for: persistent nausea that is stopping you eating or drinking normally; dizziness or light-headedness that does not settle; a significant change in your resting pulse that concerns you; or any new symptom you are unsure about. A question our prescribers hear regularly: "is this a normal side effect or something I should worry about?" The honest answer is that most GI symptoms are expected and transient, but a prescriber should hear about anything that feels out of proportion or lasts longer than two weeks at a stable dose.

For context on how timing affects what you feel, our page on when Wegovy side effects tend to appear may be useful. And if you're thinking about the longer picture, we've also covered what long-term use of Wegovy looks like from a safety standpoint.

How a prescriber weighs cardiovascular benefit against individual risk

There is no single answer to whether Wegovy is safe for every person with heart disease. The decision turns on what kind of cardiovascular condition you have, how stable it is, what other medicines you take, and what your weight-related health picture looks like. For someone who is stable following a heart attack two years ago with well-controlled blood pressure and no significant arrhythmia, the risk-benefit calculation often looks favourable. For someone who had a cardiac event last month or who has poorly controlled heart failure, the timing conversation is different.

Wegovy is a prescription-only medicine for exactly this reason. A prescriber who reviews your answers (and at nume, that is always a GPhC-registered Independent Prescriber reading your consultation personally) considers the clinical whole, not just the BMI box. If the picture is complex, they may write to your GP or suggest a conversation with your cardiologist before prescribing. That is not a barrier; it is the process working as it should.

Our Wegovy overview page covers eligibility and the full treatment pathway if you want to understand what a private prescription route looks like from the start. You can also explore the broader evidence on Wegovy's safety for weight loss alongside the cardiovascular data. When you're ready to discuss your own situation, our prescribers go through suitability and any side-effect concerns as part of the free consultation, there are no rushed boxes to tick.